BSE Live
Oct 10, 16:01Prev. Close
1095.70
Open Price
1099.15
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Oct 10, 15:53Prev. Close
1098.00
Open Price
1110.80
Bid Price (Qty.)
1124.20 (233)
Offer Price (Qty.)
0.00 (0)
Balance Sheet of Jubilant Pharmova (in Rs. Cr.) | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 15.80 | 15.80 | 15.91 | 15.92 | 15.92 | |
Total Share Capital | 15.80 | 15.80 | 15.91 | 15.92 | 15.92 | |
Reserves and Surplus | 6,239.10 | 5,418.10 | 5,383.37 | 5,302.64 | 4,725.57 | |
Total Reserves and Surplus | 6,239.10 | 5,418.10 | 5,383.37 | 5,302.64 | 4,725.57 | |
Total Shareholders Funds | 6,254.90 | 5,433.90 | 5,399.28 | 5,318.56 | 4,741.49 | |
Minority Interest | -16.30 | -12.80 | -7.49 | -2.16 | 0.03 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 2,150.30 | 3,167.10 | 3,110.36 | 2,464.24 | 2,563.97 | |
Deferred Tax Liabilities [Net] | 172.20 | 210.80 | 306.21 | 302.97 | 247.30 | |
Other Long Term Liabilities | 1,911.60 | 760.40 | 483.64 | 219.99 | 222.48 | |
Long Term Provisions | 119.10 | 100.10 | 92.25 | 95.67 | 94.01 | |
Total Non-Current Liabilities | 4,353.20 | 4,238.40 | 3,992.46 | 3,082.87 | 3,127.76 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 286.60 | 247.00 | 299.72 | 463.37 | 20.00 | |
Trade Payables | 1,004.80 | 856.30 | 821.32 | 567.74 | 520.48 | |
Other Current Liabilities | 794.80 | 719.30 | 573.02 | 473.65 | 418.54 | |
Short Term Provisions | 78.40 | 66.40 | 78.35 | 86.84 | 89.81 | |
Total Current Liabilities | 2,164.60 | 1,889.00 | 1,772.40 | 1,591.60 | 1,048.83 | |
Total Capital And Liabilities | 12,756.40 | 11,548.50 | 11,156.65 | 9,990.87 | 8,918.11 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 2,453.50 | 2,434.80 | 2,591.87 | 2,499.27 | 2,297.41 | |
Intangible Assets | 181.40 | 192.50 | 162.80 | 128.58 | 181.37 | |
Capital Work-In-Progress | 2,714.70 | 1,252.30 | 773.25 | 291.83 | 277.78 | |
Fixed Assets | 6,264.90 | 4,730.40 | 4,316.16 | 3,717.42 | 3,375.78 | |
Non-Current Investments | 43.50 | 42.20 | 256.42 | 238.60 | 240.96 | |
Deferred Tax Assets [Net] | 257.40 | 232.70 | 227.44 | 161.27 | 154.71 | |
Long Term Loans And Advances | 0.30 | 0.30 | 0.43 | 0.55 | 13.71 | |
Other Non-Current Assets | 72.10 | 202.90 | 165.21 | 121.08 | 50.49 | |
Total Non-Current Assets | 9,179.20 | 7,672.40 | 7,394.25 | 6,481.68 | 5,965.61 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 1,129.20 | 1,289.60 | 1,380.53 | 1,254.87 | 1,129.38 | |
Trade Receivables | 891.50 | 915.90 | 961.24 | 927.99 | 819.90 | |
Cash And Cash Equivalents | 1,088.80 | 956.80 | 1,014.30 | 984.24 | 671.32 | |
Short Term Loans And Advances | 1.10 | 0.80 | 1.14 | 1.40 | 1.43 | |
OtherCurrentAssets | 466.60 | 713.00 | 405.19 | 340.69 | 330.47 | |
Total Current Assets | 3,577.20 | 3,876.10 | 3,762.40 | 3,509.19 | 2,952.50 | |
Total Assets | 12,756.40 | 11,548.50 | 11,156.65 | 9,990.87 | 8,918.11 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 1,214.10 | 1,360.40 | 1,256.59 | 842.82 | 887.12 | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | 4.40 | 4.40 | 4.40 | 4.40 | 4.40 | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Non-Current Investments Unquoted Book Value | 36.00 | 34.40 | 32.79 | 43.49 | 42.82 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Current Investments Unquoted Book Value | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
30.07.2025
Jubilant Pharmo Consolidated June 2025 Net Sales at Rs 1,900.70 crore, up 9.76% Y-o-Y
30.07.2025
Jubilant Pharmo Standalone June 2025 Net Sales at Rs 59.50 crore, down 64.31% Y-o-Y
20.07.2025
16.06.2025
30.07.2025
Jubilant Pharmo Consolidated June 2025 Net Sales at Rs 1,900.70 crore, up 9.76% Y-o-Y
30.07.2025
Jubilant Pharmo Standalone June 2025 Net Sales at Rs 59.50 crore, down 64.31% Y-o-Y
16.05.2025
Jubilant Pharmo Consolidated March 2025 Net Sales at Rs 1,928.80 crore, up 9.68% Y-o-Y
16.05.2025
Jubilant Pharmo Standalone March 2025 Net Sales at Rs 217.30 crore, up 5.59% Y-o-Y
18.01.2021
Jubilant Life Sciences Q3 PAT seen up 14.9% YoY to Rs. 238 cr: Prabhudas Lilladher
12.07.2019
Jubilant Life Sciences Q1 PAT may dip 10.4% YoY to Rs. 181.4 cr: Prabhudas Lilladher
12.04.2019
Jubilant Life Sciences Q4 PAT seen up 36.3% YoY to Rs. 211.2 cr: Prabhudas Lilladher
11.01.2019
Jubilant Life Science Q3 PAT seen up 13.8% YoY to Rs. 241.8 cr: ICICI Direct